Scientists test groundwork for future Parkinson's pill in healthy volunteers
NCT ID NCT06088784
Summary
This was an early-stage study to check the safety of a new oral drug called ATH-399A, which is being developed to treat Parkinson's disease. Researchers gave the drug to 76 healthy adult volunteers to see how their bodies reacted to it and processed it, including whether taking it with food made a difference. The main goal was to gather basic safety information to see if the drug is suitable for future testing in people who actually have Parkinson's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Syneos Quebec Canada
Québec, QC G1P 0A2, Canada
Conditions
Explore the condition pages connected to this study.